Organ Preservation Solution Market Report 2026

Organ Preservation Solution Market Overview

• Organ Preservation Solution market size has reached to $0.31 billion in 2025 • Expected to grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Increasing Healthcare Spending Fuels Growth Of The Organ Preservation Solution Market • Market Trend: Paragonix Technologies Launches The FDA-Cleared Pancreaspak Organ Preservation System • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Organ Preservation Solution Market?

Organ preservation solutions are specially formulated solutions used to preserve organs during transplantation or storage. These solutions serve to safeguard organs from potential damage during the transplantation procedure and prolong the duration for which organs can be stored outside of the body. They may consist of specific agents designed to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action. The main types of organ preservation solutions are viaspan, custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), renograf, hypothermosol, perfadex, lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan is an organ preservation solution used for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys and helps maintain organ viability during transportation and before transplantation. They are used to preserve organs such as kidneys, liver, lungs, hearts, and others with techniques including static cold storage (SCS) techniques, hypothermic machine perfusion, and others.

What Is The Organ Preservation Solution Market Growth Forecast?

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $0.43 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing organ transplant demand, rising adoption of advanced preservation technologies, expansion of machine perfusion systems, growing focus on transplant success rates, innovation in organ protection formulations. Major trends in the forecast period include advancements in ischemia-reperfusion injury mitigation, rising adoption of machine perfusion techniques, growing use of multi-organ preservation solutions, expansion of transplant storage durations, enhanced focus on organ viability.

Global Organ Preservation Solution Market Segmentation

1) By Solution Type: Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Hypothermosol, Perfadex, Other Solution Types 2) By Organ Type: Kidneys, Liver, Lung, Heart, Other Organ Types 3) By Technique: Static Cold Storage (SCS) Technique, Hypothermic Machine Perfusion, Other Techniques Subsegments: 1) By Viaspan: Standard Viaspan, Modified Viaspan Formulations 2) By Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate): Custodiol Formulations: Variants With Additives 3) By Hypothermosol: Hypothermosol For Various Organs, Custom Hypothermosol Mixes 4) By Perfadex: Perfadex For Lung Preservation, Adapted Perfadex Formulations 5) By Other Solution Types: Experimental Preservation Solutions, Emerging Organ Preservation Technologies

What Is The Driver Of The Organ Preservation Solution Market?

The increase in healthcare spending is driving the growth of the organ preservation solution market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending utilizes organ preservation solutions to optimize the success of organ transplantation procedures. These solutions are used to preserve organs during transportation and storage, ensuring their viability for transplantation. The investment in organ preservation solutions contributes to improved organ transplant outcomes, reducing the need for transplantation and associated healthcare costs. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based Institute for Health Information, in 2023, total health spending in Canada is projected to reach $344 billion, equating to $8,740 per person. This marks a 2.8% increase compared to the previous year, which saw only a 1.5% growth in health spending in 2022, indicating a notable rebound in healthcare investment. Therefore, an increase in healthcare spending is driving the growth of the organ preservation solution industry going forward.

What Is The Driver Of The Organ Preservation Solution Market?

The increase in healthcare spending is driving the growth of the organ preservation solution market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending utilizes organ preservation solutions to optimize the success of organ transplantation procedures. These solutions are used to preserve organs during transportation and storage, ensuring their viability for transplantation. The investment in organ preservation solutions contributes to improved organ transplant outcomes, reducing the need for transplantation and associated healthcare costs. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based Institute for Health Information, in 2023, total health spending in Canada is projected to reach $344 billion, equating to $8,740 per person. This marks a 2.8% increase compared to the previous year, which saw only a 1.5% growth in health spending in 2022, indicating a notable rebound in healthcare investment. Therefore, an increase in healthcare spending is driving the growth of the organ preservation solution industry going forward.

Global Organ Preservation Solution Market Trends and Insights

Major companies operating in the organ preservation solution market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in June 2024, Paragonix Technologies, a US-based organ preservation technology company launched PancreasPak Organ Preservation System. This is the first FDA-cleared device specifically created to safeguard and monitor donor pancreases during transportation, highlighting its importance in organ transplantation. The system provides a controlled environment that maintains the pancreas within an optimal thermal range of 4-8°C, which is essential for preserving the organ's viability and functionality during transport that can last up to 21 hours. PancreasPak is equipped with digital monitoring features that continuously track the temperature and surrounding conditions of the pancreas. This real-time data allows for quick responses to any deviations from optimal conditions, thereby improving organ preservation.

What Are Latest Mergers And Acquisitions In The Organ Preservation Solution Market?

In September 2024, Getinge, a Sweden-based medical technology company, acquired Paragonix Technologies for $253 million. By acquiring Paragonix, Getinge aims to enter the rapidly evolving organ preservation and transportation market, which is experiencing significant growth due to increasing transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company that provides organ preservation solutions.

Regional Insights

North America was the largest region in the organ preservation solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Organ Preservation Solution Market?

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Organ Preservation Solution Market Report 2026?

The organ preservation solution market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.